Biomark Diagnostics (FRA:20B) Common Stock : €6.96 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Common Stock?

Biomark Diagnostics's quarterly common stock declined from Jun. 2023 (€5.72 Mil) to Sep. 2023 (€5.71 Mil) but then increased from Sep. 2023 (€5.71 Mil) to Dec. 2023 (€6.96 Mil).

Biomark Diagnostics's annual common stock increased from Mar. 2021 (€4.60 Mil) to Mar. 2022 (€5.11 Mil) and increased from Mar. 2022 (€5.11 Mil) to Mar. 2023 (€5.62 Mil).

Biomark Diagnostics Common Stock Historical Data

The historical data trend for Biomark Diagnostics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Common Stock Chart

Biomark Diagnostics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Common Stock

Get a 7-Day Free Trial

2.78

3.52

4.60

5.11

5.62

Biomark Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															5.73	5.62	5.72	5.71	6.96

Biomark Diagnostics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Biomark Diagnostics (FRA:20B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

BMKDF:USA BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines